Calvin Chen Email & Phone Number

At Novo Nordisk, our team is at the forefront of forging partnerships and seizing opportunities that have the potential to revolutionize the management and treatment of serious chronic diseases.We are on a constant quest for novel targets, compounds, and technologies that could meet the unmet needs of patients battling diabetes, obesity, cardiovascular diseases, chronic kidney diseases, MASH, and various rare blood and endocrine disorders.Our search extends to cutting-edge technologies and platforms that are reshaping drug discovery. We are particularly interested in innovations related to oligonucleotide or RNA-based therapies, advanced peptide and protein engineering, as well as sophisticated formulation and drug delivery systems, especially those enhancing oral bioavailability and enabling targeted delivery at the cellular and tissue levels.Furthermore, we are actively seeking stem cell therapeutic programs, at any stage of development for treating serious chronic diseases. Our interests include, but are not limited to, cell encapsulation, novel medical devices, engraftment technologies; stealth modalities, biomaterials, scaffolds; cell cryopreservation, formulation, delivery technologies; GMP-grade pluripotent cell lines, GMP production and upscaling technologies.We are also pursuing AI-driven platforms for target discovery, drug design, and development, aiming to accelerate the journey from concept to cure.

• 

  Utrecht University

  Regenerative Medicine